Keith Gottesdiener

Direktor/Vorstandsmitglied bei SEPTERNA, INC.

Vermögen: 15 Mio $ am 31.05.2026

72 Jahre

92 Beziehungen

Health Technology

Consumer Services

Finance

Profil

Keith M.
Gottesdiener is currently Chief Executive Officer at Excellentia Global Partners, Independent Director at Septerna, Inc. starting in 2025, Director at Cardurion Pharmaceuticals, Inc., and Senior Advisor at Samsara BioCapital LLC.
Former roles include President, Chief Executive Officer & Director at Prime Medicine, Inc. from 2020 to 2025; Chief Executive Officer & Director at Allergan GI Corp.
from 2011 to 2014; President, Chief Executive Officer & Director at Rhythm Pharmaceuticals, Inc. from 2017 to 2020; Independent Director at Intercept Pharmaceuticals, Inc. from 2016 to 2023; Associate Clinical Professor-Medicine at The Trustees of Columbia University in The City of New York from 1986 to 1995; Vice President at Merck Research Laboratories Massachusetts LLC from 1995 to 2011; Associate at Columbia University College of Physicians & Surgeons from 1987 to 2004; and Head-Late Development at Schering-Plough Corp.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
PRIME MEDICINE, INC. 2.53%	31.03.2026	4’361’078 ( 2.53% )	15 Mio $	31.05.2026
SEPTERNA, INC. -.--%	29.04.2026	0 ( -.--% )	- $	31.05.2026

Aktive Positionen von Keith Gottesdiener

Unternehmen	Position	Beginn
SEPTERNA, INC.	Direktor/Vorstandsmitglied	25.09.2025
Cardurion Pharmaceuticals, Inc. Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases	Direktor/Vorstandsmitglied	-
Excellentia Global Partners Excellentia Global Partners Financial ConglomeratesFinance Provides investment and advisory services	Vorstandsvorsitzender	-
Samsara Biocapital LLC Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements.	Berater	-

Alle aktiven Positionen von Keith Gottesdiener

Ehemalige bekannte Positionen von Keith Gottesdiener

Unternehmen	Position	Ende
PRIME MEDICINE, INC.	Vorstandsvorsitzender	18.05.2025
INTERCEPT PHARMACEUTICALS, INC.	Direktor/Vorstandsmitglied	08.11.2023
RHYTHM PHARMACEUTICALS, INC.	Vorstandsvorsitzender	28.03.2020
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Corporate Officer/Principal	01.10.2011
Columbia University College of Physicians & Surgeons Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01.01.2004

Sehen Sie sich die Erfahrung von Keith Gottesdiener im Detail an

Ausbildung von Keith Gottesdiener

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Keith Gottesdiener im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	14
Schering-Plough Corp. Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products	Health Technology
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases	Health Technology
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Health Technology
Allergan GI Corp. Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases	Health Technology
Columbia University College of Physicians & Surgeons Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Excellentia Global Partners Excellentia Global Partners Financial ConglomeratesFinance Provides investment and advisory services	Finance
Cardurion Pharmaceuticals, Inc. Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases	Health Technology
Samsara Biocapital LLC Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements.	Finance
Prime Medicine, Inc. Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology	Health Technology
Septerna, Inc. Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism	Health Technology